
Piperaquine
CAS No. 4085-31-8
Piperaquine( —— )
Catalog No. M20898 CAS No. 4085-31-8
Piperaquine is a bis-quinoline compound that inhibits the ex vivo growth of P. falciparum isolates from malaria-infected patients with IC50s ranging from 11.8-217.3 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 75 | Get Quote |
![]() ![]() |
5MG | 107 | Get Quote |
![]() ![]() |
10MG | 154 | Get Quote |
![]() ![]() |
25MG | 308 | Get Quote |
![]() ![]() |
50MG | 525 | Get Quote |
![]() ![]() |
100MG | 786 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePiperaquine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiperaquine is a bis-quinoline compound that inhibits the ex vivo growth of P. falciparum isolates from malaria-infected patients with IC50s ranging from 11.8-217.3 nM.
-
DescriptionPiperaquine is a bis-quinoline compound that inhibits the ex vivo growth of P. falciparum isolates from malaria-infected patients with IC50s ranging from 11.8-217.3 nM.
-
In Vitro——
-
In VivoPiperaquine (10-90 mg/kg; a single i.p.) decreases parasitemia at all of the doses tested in mice.Piperaquine (90 mg/kg; a single i.p.) exhibits the t1/2, apparent clearance, and apparent volume of distribution 17.8 days, 33.5 mg?h/L, 1.55 L/h/kg, and 956 L/kg, respectively, in healthy mice and 16.1 days, 27.3 mg?h/L, 1.9 L/h/kg, and 1,059 L/kg in malaria-infected mice.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptorParasite
-
Research AreaInfection
-
IndicationFalciparum malaria; Vivax malaria
Chemical Information
-
CAS Number4085-31-8
-
Formula Weight535.5
-
Molecular FormulaC29H32Cl2N6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
ELQ-300
ELQ-300 is bioavailable antimalarial agent acts as an inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (cyt bc1).
-
Ganaplacide
Ganaplacide (KAF156, GNF-156)?is a novel antimalarial clinical candidate that shows blood schizonticidal activity with IC50 of 6-17.4 nM against P falciparum drug-sensitive and drug-resistant strains.
-
Rafoxanide
A salicylanilide anthelmintic agent that also shows to be an allosteric inhibitor of SPAK and OSR1.